Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

12.90
-0.4100-3.08%
Volume:979.28K
Turnover:12.68M
Market Cap:2.19B
PE:-4.93
High:13.33
Open:12.77
Low:12.72
Close:13.31
Loading ...
Aug 02, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 13, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 01, 2021

Major Issues Report

8-K - Current report
Mar 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 17, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 25, 2020

Major Issues Report

8-K - Current report